GlaxoSmithKline received approval from the FDA for its Rotarix vaccine for the prevention of rotavirus gastroenteritis in infants. With two doses, Rotarix offers protection against the most common rotavirus types in the U.S. and allows infants to complete the vaccination series by four months of age. The U.S. Centers for Disease Control and Prevention (CDC) currently recommends that children complete the rotavirus immunization series by six months of age. Rotavirus infects virtually every child ...